Early Discharge and Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. An International Multicentre Single-arm Clinical Trial - Barco, S; Schmidtmann, I; Ageno, W (Eur Heart J, 2020)